v3.25.4
Financial instruments - Derivative and non-derivative financial instruments (Details)
€ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended 36 Months Ended
Dec. 31, 2025
EUR (€)
Aug. 31, 2025
Sep. 30, 2025
EUR (€)
Sep. 30, 2025
USD ($)
Apr. 30, 2024
item
Dec. 31, 2025
EUR (€)
GWh / yr
Dec. 31, 2025
USD ($)
GWh / yr
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
EUR (€)
Dec. 31, 2025
EUR (€)
item
Reconciliation of changes in fair value measurement                    
Distributions to noncontrolling interests           € 573,971   € 313,691 € 313,365  
Transactions with noncontrolling interests without loss of control           (360,028)   (55,905) (5,962)  
Put option liabilities           364,649   155,850 39,474  
Income tax expense           320,971   316,056 300,557  
Assets at beginning of period           33,566,579   33,929,808    
Assets at end of period € 31,002,333         31,002,333   33,566,579 33,929,808 € 31,002,333
Liabilities at beginning of period           17,798,066        
Liabilities at end of period € 16,719,524         16,719,524   17,798,066   16,719,524
InterWell Health LLC                    
Reconciliation of changes in fair value measurement                    
Ownership percentage 92.00% 75.00%                
Noncontrolling interests                    
Reconciliation of changes in fair value measurement                    
Transactions with noncontrolling interests without loss of control           (85,806)   (20,982) (14,684)  
Additional paid-in capital                    
Reconciliation of changes in fair value measurement                    
Transactions with noncontrolling interests without loss of control           (274,222)   (34,923) 8,722  
Retained earnings                    
Reconciliation of changes in fair value measurement                    
Put option liabilities           364,649   155,850 39,474  
Shareholders of Interwell Health                    
Reconciliation of changes in fair value measurement                    
Settlement of put options held by non-physician investors     € 311,614 $ 363,272            
Distributions to noncontrolling interests           311,614        
Increase (decrease) in put option liabilities           (312,941)        
Income tax expense           (34,679) $ (38,792)      
Shareholders of Interwell Health | Noncontrolling interests                    
Reconciliation of changes in fair value measurement                    
Transactions with noncontrolling interests without loss of control           (76,201)        
Shareholders of Interwell Health | Additional paid-in capital                    
Reconciliation of changes in fair value measurement                    
Transactions with noncontrolling interests without loss of control           (235,413)        
Shareholders of Interwell Health | Retained earnings                    
Reconciliation of changes in fair value measurement                    
Put option liabilities           € 312,941        
Maximum                    
Reconciliation of changes in fair value measurement                    
Term of virtual power purchase agreement         15 years          
Germany                    
Reconciliation of changes in fair value measurement                    
Number of wind and solar energy project developers who signed contracts with company | item         2          
Annual electricity production under VPPAs | GWh / yr           106 106      
United States                    
Reconciliation of changes in fair value measurement                    
Number of wind and solar energy project developers who signed contracts with company | item         1          
Annual electricity production under VPPAs | GWh / yr           423 423      
Percentage of company's 2025 electricity consumption covered by vPPAs           50.00% 50.00%      
European Union                    
Reconciliation of changes in fair value measurement                    
Percentage of company's 2025 electricity consumption covered by vPPAs           61.00% 61.00%      
Derivatives embedded in vPPAs | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Opening balance net assets (liabilities) January 1,           € (25,394)        
Settlements           10,867   460    
Gain (loss) recognized in profit or loss           11,308   (24,959)    
Foreign currency translation and other changes           1,486   (895)    
Closing balance net assets (liabilities) December 31, € (1,733)         € (1,733)   € (25,394)   € (1,733)
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected electricity prices                    
Reconciliation of changes in fair value measurement                    
Increase in input 10.00%         10.00%   10.00%   10.00%
Decrease in input 10.00%         10.00%   10.00%   10.00%
Sensitivity of derivatives embedded in vPPAs to increase in input           € 24,356   € 26,774    
Sensitivity of derivatives embedded in vPPAs to decrease in input           € (24,305)   € (26,761)    
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected production volumes                    
Reconciliation of changes in fair value measurement                    
Increase in input 10.00%         10.00%   10.00%   10.00%
Decrease in input 10.00%         10.00%   10.00%   10.00%
Sensitivity of derivatives embedded in vPPAs to increase in input           € 155   € (2,540)    
Sensitivity of derivatives embedded in vPPAs to decrease in input           € (155)   € 2,540    
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected interest rates                    
Reconciliation of changes in fair value measurement                    
Increase in input 1.00%         1.00%   1.00%   1.00%
Decrease in input 1.00%         1.00%   1.00%   1.00%
Sensitivity of derivatives embedded in vPPAs to increase in input           € (183)   € 2,247    
Sensitivity of derivatives embedded in vPPAs to decrease in input           196   (2,507)    
Equity investments | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Assets at beginning of period           29,154   32,002 42,793 € 42,793
Increase           2,002   3,085 4,833  
Gain / loss recognized in profit or loss           (14,487)   (7,773) (14,340)  
Foreign currency translation and other changes           (2,898)   1,840 (1,284)  
Assets at end of period € 13,771         13,771   29,154 32,002 13,771
Other financial assets measured at FVPL | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Assets at beginning of period           142,264        
Increase           7,808   41,225    
Decrease           (22,855)   (2,292)    
Reclassifications               90,457    
Gain / loss recognized in profit or loss           (13,460)   4,987    
Foreign currency translation and other changes           (14,603)   7,887    
Assets at end of period 99,154         99,154   142,264   99,154
Acquisition Variable Payments Payable | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Liabilities at beginning of period           7,933   35,751 37,846 37,846
Increase           1,507   86 5,232  
Decrease           (4,581)   (23,472) (3,603)  
Gain / loss recognized in profit or loss           (928)   (4,796) (3,366)  
Foreign currency translation and other changes           (669)   364 (358)  
Liabilities at end of period 3,262         3,262   7,933 35,751 3,262
Put option liabilities                    
Reconciliation of changes in fair value measurement                    
Liabilities at beginning of period           1,299,117   1,372,008    
Liabilities at end of period 793,043         793,043   1,299,117 1,372,008 793,043
Put option liabilities exercisable 438,740         438,740   527,592 563,692 € 438,740
Number of put options exercised | item                   47
Consideration for put options exercised                   € 81,325
Put option liabilities | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Liabilities at beginning of period           1,299,117   1,372,008 1,468,517 1,468,517
Increase           32,307   8,127 31,050  
Decrease           (341,992)   (71,990) (42,490)  
Gain / loss recognized in equity           (54,964)   (91,987) (28,034)  
Foreign currency translation and other changes           (141,425)   82,959 (57,035)  
Liabilities at end of period € 793,043         € 793,043   € 1,299,117 € 1,372,008 € 793,043
Put option liabilities | Fair Value | Level 3 | Assumed earnings or enterprise value                    
Reconciliation of changes in fair value measurement                    
Increase in input, liabilities 10.00%         10.00%       10.00%
Increase (decrease) in fair value due to increase in input, liabilities           € 61,570        
Put option liabilities | Fair Value | Level 3 | Assumed earnings or enterprise value | Maximum                    
Reconciliation of changes in fair value measurement                    
Increase in fair value due to increase in input, as percentage of total liabilities 1.00%         1.00%       1.00%
Increase in fair value due to increase in input, as percentage of equity 1.00%         1.00%       1.00%